Let's also remember, none of the big pharma players are in the canaloplasty MIGS space.
In 2016, Allergen bought stent company/procedure Aquesys for $300m. Alcon bought Ivantus (mad ethe Hydrus stent) for $475m.
These purchases gives some idea of the imbedded value of these procedures!
Nova Eye Medical (EYE) Discussion, page-6
-
- There are more pages in this discussion • 3,182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $35.50M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.5¢ | $13.41K | 86.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 581087 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 150000 | 2 |
View Market Depth
| Last trade - 13.10pm 15/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |